Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:73 |
|---|---|
| Enthalten in: |
The Journal of antimicrobial chemotherapy - 73(2018), 4 vom: 01. Apr., Seite 1104-1106 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shaw, Evelyn [VerfasserIn] |
|---|
| Links: |
|---|
| Anmerkungen: |
Date Completed 14.05.2019 Date Revised 14.05.2019 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/jac/dkx496 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM279360746 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM279360746 | ||
| 003 | DE-627 | ||
| 005 | 20231225022802.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jac/dkx496 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0931.xml |
| 035 | |a (DE-627)NLM279360746 | ||
| 035 | |a (NLM)29272413 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shaw, Evelyn |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Clinical outcomes after combination treatment with ceftazidime/avibactam and aztreonam for NDM-1/OXA-48/CTX-M-15-producing Klebsiella pneumoniae infection |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 14.05.2019 | ||
| 500 | |a Date Revised 14.05.2019 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 7 | |a Anti-Bacterial Agents |2 NLM | |
| 650 | 7 | |a Azabicyclo Compounds |2 NLM | |
| 650 | 7 | |a Drug Combinations |2 NLM | |
| 650 | 7 | |a avibactam, ceftazidime drug combination |2 NLM | |
| 650 | 7 | |a beta-Lactamase Inhibitors |2 NLM | |
| 650 | 7 | |a Ceftazidime |2 NLM | |
| 650 | 7 | |a 9M416Z9QNR |2 NLM | |
| 650 | 7 | |a beta-lactamase CTX-M-15 |2 NLM | |
| 650 | 7 | |a EC 3.5.2.- |2 NLM | |
| 650 | 7 | |a beta-Lactamases |2 NLM | |
| 650 | 7 | |a EC 3.5.2.6 |2 NLM | |
| 650 | 7 | |a beta-lactamase NDM-1 |2 NLM | |
| 650 | 7 | |a EC 3.5.2.6 |2 NLM | |
| 650 | 7 | |a oxacillinase |2 NLM | |
| 650 | 7 | |a EC 3.5.2.6 |2 NLM | |
| 650 | 7 | |a Aztreonam |2 NLM | |
| 650 | 7 | |a G2B4VE5GH8 |2 NLM | |
| 700 | 1 | |a Rombauts, Alexander |e verfasserin |4 aut | |
| 700 | 1 | |a Tubau, Fe |e verfasserin |4 aut | |
| 700 | 1 | |a Padullés, Ariadna |e verfasserin |4 aut | |
| 700 | 1 | |a Càmara, Jordi |e verfasserin |4 aut | |
| 700 | 1 | |a Lozano, Toni |e verfasserin |4 aut | |
| 700 | 1 | |a Cobo-Sacristán, Sara |e verfasserin |4 aut | |
| 700 | 1 | |a Sabe, Núria |e verfasserin |4 aut | |
| 700 | 1 | |a Grau, Imma |e verfasserin |4 aut | |
| 700 | 1 | |a Rigo-Bonnin, Raül |e verfasserin |4 aut | |
| 700 | 1 | |a Dominguez, M Angeles |e verfasserin |4 aut | |
| 700 | 1 | |a Carratalà, Jordi |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The Journal of antimicrobial chemotherapy |d 1981 |g 73(2018), 4 vom: 01. Apr., Seite 1104-1106 |w (DE-627)NLM000017701 |x 1460-2091 |7 nnns |
| 773 | 1 | 8 | |g volume:73 |g year:2018 |g number:4 |g day:01 |g month:04 |g pages:1104-1106 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jac/dkx496 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 73 |j 2018 |e 4 |b 01 |c 04 |h 1104-1106 | ||